N2OFF, Inc. Common Stock (NITO) is a publicly traded Basic Materials sector company. As of May 21, 2026, NITO trades at $1.22 with a market cap of $3.31M and a P/E ratio of -0.34. NITO moved +29.10% today. Year to date, NITO is -71.50%; over the trailing twelve months it is -93.93%. Its 52-week range spans $0.77 to $122.15. Rallies surfaces NITO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
N2OFF to Become Nexentis with New Trading Symbol, Biotech Focus: N2OFF will change its name to Nexentis Technologies and ticker to NXTS on Nasdaq on Feb. 26, 2026, reflecting its transformation into an AI-driven computational biotech platform. The company completed acquisition of MitoCareX, integrating its MITOLINE™ discovery engine to develop mitochondrial-targeted oncology and anti-inflammatory drug candidates.
| Metric | Value |
|---|---|
| Price | $1.22 |
| Market Cap | $3.31M |
| P/E Ratio | -0.34 |
| EPS | $-3.54 |
| Dividend Yield | 0.00% |
| 52-Week High | $122.15 |
| 52-Week Low | $0.77 |
| Volume | 1.64M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-4.16M |
| Gross Margin | 0.00% |
NITO analyst coverage data. Average price target: $0.00.